CIPAP therapy is a method of sleep apnea treatment by means of artificial ventilation with constant positive pressure. Scientists of Cleveland Clinic have found that CIPAP therapy is useful for people with epilepsy suffering from sleep apnea. Due to this therapy, the number of epileptic seizures is reduced, UPI.com reports.
It has long been known that HIV-positive people often face problems such as depression and forgetfulness. However, until now, scientists did not know whether this is a consequence of somatic diseases of these people, or the virus is able to affect the brain directly.
The needle was designed by Australian scientists. It has a tiny fiber-optic camera that helps surgeons during the surgery to see what vessels are at risk and to prevent their damage. It is interesting that namely computer detects the threat and notifies surgeons about it, Business Standard reports.
Only a drop of blood is required for a new test detecting 30-40 biomarkers of the disease. Results can be received within 24 hours. This method will change the diagnosis of bowel cancer. As The Daily Mail notes, some patients will not be subjected to unpleasant and dangerous colonoscopy any more.
Researchers from Georgetown University say that drugs suppressing the growth of cancer tumors also affect blood pressure. These are fibroblast growth factor inhibitors involved in angiogenesis (new blood vessels formation).
Scientists have identified more than 100 genes acting as risk factors for severe allergic reactions, hay fever, eczema and asthma, Zee News reports. Earlier, it has been already established that these ailments have a single genetic basis. However, geneticists did not know where the problem genes affecting the functioning of the immune system exactly were.
Previous studies have shown that proton pump inhibitors, which are usually prescribed for heartburn and other acid-related diseases, increase the risk of developing dementia. But now experts have disproved this. According to The Deccan Chronicle, the researchers have analyzed the data of 3484 adults aged 65 and over.
The developers have reported on the successful completion of Myrcludex B interim tests. Myrcludex B is a drug intended to patients with chronic hepatitis B (delta agent). As "Remedium" notes, the drug has been tested on 120 patients for 24 weeks. During that time the volunteers had no serious side effects. This proves the safety of the therapy.
Glatiramer acetate is a medicinal product, used to treat multiple sclerosis for 20 years. It turns out that it is able to cope with antibiotic resistant bacteria. As Zee News notes, experts say that the drug is safe and has no serious side effects.
A new study, carried out by scientists from the United States, involved 365 people suffering from pancreatic adenocarcinoma. The tumor could be removed surgically. The researchers have found that the life expectancy of patients depends on changes in the four genes, The Indian Express reports.